Scotts Miracle-Gro

Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Scotts Miracle-Gro exceeds Q1 sales goal, eyes cannabis growth

Scotts Miracle-Gro (SMG) reported strong Q1 performance, exceeding sales goals and achieving profitability milestones.
Despite challenges in the Hawthorne segment, the company remains optimistic about growth opportunities in the cannabis sector.
Commitment to disciplined growth strategies, pricing strength, and leveraging free cash flow for debt repayment and potential reinvestment.
Focus on consumer engagement, market recovery, and maintaining liquidity to drive future success.

Scotts Miracle-Gro reports strong Q2 performance amidst industry challenges

Scotts Miracle-Gro (SMG) reported strong Q2 performance in the US Consumer business, with cost reductions and efficiency gains contributing to improved free cash flow.
While facing challenges in the Hawthorne segment, the company remains focused on reaching breakeven and aligning with the cannabis market's realities for improved performance.
Opportunities lie in positive industry developments, potential pricing adjustments, strategic partnerships in the cannabis market, and value creation initiatives.
Despite margin hindrances, Scotts Miracle-Gro (SMG) is optimistic about the season's progress and committed to growth strategies and profitability through innovation and partnerships.

Scotts Miracle-Gro faces challenges but eyes growth opportunities in 2024

Scotts Miracle-Gro faced challenges in meeting its targets but saw growth in consumer retail sales, with a focus on debt reduction and maintaining dividend payments.
The company is on track with its debt reduction plan, aiming for $1 billion over 2 years, and is exploring opportunities for margin accretion and partnerships for future growth.
Despite short-term financial challenges, Scotts Miracle-Gro is implementing cost-saving measures, focusing on broadening retailer relationships, and anticipating a return to $600 million EBITDA next year.
The Hawthorne business is stabilizing, aiming for profitability, exploring partnerships, and considering strategic actions to address industry challenges, while maintaining a commitment to debt reduction.

Scotts Miracle-Gro reports fiscal '23 improvements, eyes growth in '24

Scotts Miracle-Gro's fiscal '23 performance showcased financial discipline and operational improvements despite sales challenges, setting the stage for growth in fiscal '24.
The company's focus on core consumer, marketing, innovation, and strategic solutions positions it well to capitalize on opportunities for revenue growth and margin enhancement.
While facing challenges such as sales declines and margin pressures, Scotts Miracle-Gro's strategic outlook for fiscal '24 emphasizes growth, profitability, and operational efficiency.
By addressing concerns, leveraging data analytics, and enhancing marketing efforts, Scotts Miracle-Gro aims to drive performance and shareholder value in the upcoming year.

Scotts Miracle-Gro reports strong Q1 results, focuses on profitability

Scotts Miracle-Gro's Q1 performance reflects positive growth and margin improvement strategies.
The company is focused on profitability, leveraging strengths in North America and retail partnerships.
Challenges include managing leverage, transitioning Hawthorne to profitability, and SG&A adjustments.
Opportunities lie in volume growth, partnerships, and sustainable reinvestment for future growth.

Scotts Miracle-Gro surpasses financial targets and navigates industry challenges

Scotts Miracle-Gro delivered strong financial performance, exceeding targets and showcasing growth in consumer business. The focus on proprietary brands, partnerships, and cost optimization reflects a commitment to long-term success.
Challenges include pending deals, achieving profitability in Hawthorne, and navigating the evolving cannabis industry landscape. Opportunities in advertising, strategic partnerships, and cost optimization pave the way for future growth.
Overall, Scotts Miracle-Gro's Q2 earnings call highlighted solid performance, strategic initiatives, and a positive outlook for future sales growth. Management's focus on financial metrics, consumer engagement, and profitability sets a strong foundation for continued success.

Scotts Miracle-Gro reports strong Q3 performance and strategic growth focus

Scotts Miracle-Gro delivered a robust performance in Q3 2024, showcasing growth in net sales, profitability, and market share across its key divisions, driven by strategic initiatives and operational efficiencies.
While facing challenges related to increased SG&A expenses and market dynamics, the company's focus on debt reduction, margin improvement, and financial discipline positions it well for long-term success and sustainable growth.
With opportunities to capitalize on its strong market position, drive innovation, and optimize pricing strategies, Scotts Miracle-Gro is poised to navigate challenges and leverage growth prospects for enhanced shareholder value.

Scotts Miracle-Gro reports strong fiscal '24 performance and outlines growth plans for '25

Scotts Miracle-Gro's fiscal '24 showcased resilience and strategic progress, with a focus on cost-cutting, growth, and operational efficiency. The company is poised for sustained growth through brand investments and market strategies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FTI Consulting

PennyMac Financial Services

Momentum stocks don't usually offer attractive entry points, as the trend established by these continues for some time. So, any major reversal in trend could offer a solid buying opportunity.

3 Stocks With Momentum Anomaly to Enhance Portfolio Returns

The Scotts Miracle-Gro has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Scotts Miracle-Gro Enters Oversold Territory

Cara Therapeutics

These stocks have a lot of potential growth, but which one is more of a sure thing today?

Better Buy: Cara Therapeutics vs. Scotts Miracle-Gro

Home Depot

Here are two well-known brands that are tied together but still very different. Is one a better investment than the other?

Better Buy:  Scotts Miracle-Gro vs. Home Depot

Upbeat view and bright prospects in the Hawthorne unit makes Scotts Miracle-Gro (SMG) an attractive investment option.

Here's Why You Should Add Scotts Miracle-Gro (SMG) Stock Now

Which stock wins in a matchup between a top ancillary provider to the cannabis industry and a small Canadian cannabis producer?

Better Marijuana Stock: Scotts Miracle-Gro vs. Supreme Cannabis

Scotts Miracle-Gro (SMG) is expected to utilize the net proceeds from the offering to redeem all of its outstanding 6% senior notes due 2023.

Scotts Miracle-Gro Upsizes & Prices Senior Notes Due 2029

MARYSVILLE, Ohio, Oct.  08, 2019  (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG) announced today the pricing of its offering of $450 million aggregate principal amount of 4.500% senior notes due 2029 (the “Senior Notes”). This represents a $50 million increase in the original offering amount of the Senior Notes. The offering of the Senior Notes has not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and the Senior Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The sale of the Senior Notes is subject to customary closing conditions and is expected to close on October 22, 2019.

The Scotts Miracle-Gro Company Announces Upsizing and Pricing of $450 Million Aggregate Principal Amount of Senior Notes due 2029

Scotts Miracle-Gro Co’s (NYSE: SMG) cannabis division seems poised for growth, while expectations seem to be low for the company’s performance in the fiscal fourth quarter, according to Bank of America Merrill Lynch.

Bank Of America Upgrades Scotts Miracle-Gro, High On Cannabis Prospects

But do low volatility metrics translate to high confidence for these stocks' future prospects?

The 3 Least-Volatile Pot Stocks on the Market

Innovative Industrial Properties

These two ancillary cannabis stocks both pay a dividend and should prove less risky and volatile than many stocks in the sector.

Better Marijuana Stock Buy: Scotts Miracle-Gro vs. Innovative Industrial Properties

Although not a pure play on pot, Scotts Miracle-Gro's approach to the space may give it more opportunity than a grower if this trend holds up

Scotts Miracle-Gro Might Have the Best Marijuana Strategy

Altria

Constellation Brands

Yes, you can generate recurring income from cannabis stocks.

4 Big-Time Dividend Stocks With Marijuana Exposure

Keysight

NewMarket

Pilgrim's Pride

The U.S. economy is likely to maintain its long-term growth albeit at a slow pace. Several stimulus measures across the globe will also help the U.S.

5 Top Growth Stocks for September to Ride on Market Rally

These two pick-and-shovel cannabis stocks offer investors less volatile options for profitng from the legal marijuana industry.

Better Buy: Scotts Miracle-Gro vs. Innovative Industrial Properties

Investing in pot stocks isn't the only way to cash in on the industry's rapid growth.

2 of the Safest Bets in the Cannabis Industry

Aurora Cannabis

Canopy Growth

Cronos Group

HEXO Corp

Tilray Brands

Each of these seven marijuana stocks can teach a valuable lesson into how to use technical analysis to identify important levels.

7 Marijuana Stocks With Critical Levels to Watch

Better-than-expected Q3 results, upbeat view as well as bright prospects in the Hawthorne unit are driving Scotts Miracle-Gro's (SMG) shares.

Scotts Miracle-Gro (SMG) Stock Up 16% in 3 Months: Here's Why

CannTrust Holdings

Trulieve Cannabis Corp.

Village Farms International

They're dirt cheap. But are they bargains that investors should consider buying?

5 Cheapest Pot Stocks on the Market Right Now

Scotts (SMG) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Scotts (SMG) is an Incredible Growth Stock: 3 Reasons Why

GW Pharmaceuticals

Neptune Wellness Solutions Inc.

You don't have to buy cannabis growers or pot retailers to make money in the marijuana space.

5 Ways to Invest in the Marijuana Craze With Ancillary Stocks

As the marijuana industry starts to shake out, Scotts Miracle-Gro starts to shine, but does that make it a buy?

Is Scotts Miracle-Gro a Buy?

The lawn care specialist boosted its 2019 outlook last month.

Why Scotts Miracle-Gro Stock Gained 14% in July

Chairman and CEO of The Scotts Miracle Gro Co (30-Year Financial, Insider Trades) James Hagedorn (insider trades) sold 105,703 shares of SMG on 08/06/2019 at an average price of $109.02 a share.

The Scotts Miracle Gro Co (SMG) Chairman and CEO James Hagedorn Sold $11.5 million of Shares

EVP and CCO of The Scotts Miracle Gro Co (30-Year Financial, Insider Trades) James D King (insider trades) sold 10,903 shares of SMG on 08/01/2019 at an average price of $110.33 a share.

News for Scotts Miracle-Gro Stock (SMG)